Strategy for randomised clinical trials in rare cancers

Tan, Say-Beng; Dear, Keith; Bruzzi, Paolo; Machin, David

Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Strategy for randomised clinical trials in rare cancers

Date

2003

Authors

Tan, Say-Beng

Dear, Keith

Bruzzi, Paolo

Machin, David

Publisher

BMJ Publishing Group

Abstract

Proving that a new treatment is more effective than current treatment can be difficult for rare conditions. Data from small randomised trials could, however, be made more robust by taking other related research into account.

Keywords

Keywords: accuracy; cancer therapy; clinical trial; controlled clinical trial; evidence based medicine; health education; priority journal; randomized controlled trial; review; Data Interpretation, Statistical; Humans; Neoplasms; Proportional Hazards Models; Random

URI

http://hdl.handle.net/1885/88561

Collections

ANU Research Publications

Source

BMJ - British Medical Journal

Type

Journal article

Full item page

Cultural advice

Strategy for randomised clinical trials in rare cancers

Date

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Description

Keywords

Citation

URI

Collections

Source

Type

Book Title

Entity type

Access Statement

License Rights

DOI

Restricted until